Radiopharmaceutical and Radioembolization Therapy: Clinical Guidance for Medical Physicists in Radiation Oncology.
Where this comes from
- Record sourced from PubMed, PMID 39733965.
- Also identified by DOI 10.1016/j.prro.2024.12.005.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recent advances in radiopharmaceutical therapy (RPT) and radioembolization (RE) will make these forms of therapy more prevalent in radiation oncology and nuclear medicine clinics. This article guides medical physicists in radiation oncology by summarizing current RPT and RE techniques, processes, safety, quality assurance, equipment, and others. The summarized guidance, which addresses technical considerations, may be applied broadly to develop a clinical RPT/RE program that offers multiple types of such therapies.
Medical subject headings
- Radiopharmaceuticals
- Radiation Oncology
- Embolization, Therapeutic
- Neoplasms